Contact
searchSearch
HMP Global

Type 2 Diabetes News

News
GLP-1 Receptor Agonists Linked to Reduced CRC Risk in Type 2 Diabetes Patients
05/06/2025
Riya Gandhi, MA
Patients on GLP-1RAs show lower colorectal cancer rates and higher colonoscopy use, pointing to a possible dual role in prevention and early detection.
Patients on GLP-1RAs show lower colorectal cancer rates and higher colonoscopy use, pointing to a possible dual role in prevention and early detection.
Patients on GLP-1RAs show lower...
05/06/2025
Gastroenterology
News
Study Identifies Elevated Diabetes Risk in Veterans With Serious Mental Illness and Psychotropic Medication Use
04/22/2025
Hannah Musick
An expansive study of veterans found that serious mental illness and exposure to certain psychiatric medications significantly increase the risk of type 2 diabetes, with implications for tailored monitoring and treatment strategies.
An expansive study of veterans found that serious mental illness and exposure to certain psychiatric medications significantly increase the risk of type 2 diabetes, with implications for tailored monitoring and treatment strategies.
An expansive study of veterans...
04/22/2025
Veterans Health Today
Diabetes Watch
Examining The Expanding Clinical Benefits Linked With Metformin Use
01/26/2022
Yvette C. Terrie, BS Pharm, RPh
In this column, the author outlines the latest evidence on the potential benefits of this medication, even outside the realm of type 2 diabetes.
In this column, the author outlines the latest evidence on the potential benefits of this medication, even outside the realm of type 2 diabetes.
In this column, the author...
01/26/2022
Podiatry Today
News
Effectiveness of Various Type 2 Diabetes Agents Differs With Cardiorenal Outcome
12/20/2021
Jolynn Tumolo
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various sodium glucose cotransporter 2 inhibitors and glucagon-like peptide 1 receptor agonists to determine their relative efficacy in improving cardiorenal outcomes in patients with type 2 diabetes.
Researchers compared various...
12/20/2021
First Report Managed Care
News
Glucokinase Activators Outperform Placebo in Patients With Type 2 Diabetes
11/24/2021
Jolynn Tumolo
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could be an attractive choice for the treatment of type 2 diabetes mellitus,” researchers wrote, adding that continued research was needed to understand long-term safety and efficacy.
“[Glucokinase activators] could...
11/24/2021
First Report Managed Care
News
Dentists Might be Able to Screen for Diabetes
03/05/2015
Dentists may be able to screen patients for diabetes while cleaning their teeth, a small study suggests. Researchers found that testing for diabetes using blood that appears on the gums during a routine oral cleaning might be just as...
Dentists may be able to screen patients for diabetes while cleaning their teeth, a small study suggests. Researchers found that testing for diabetes using blood that appears on the gums during a routine oral cleaning might be just as...
Dentists may be able to screen...
03/05/2015
First Report Managed Care

Visit Our Other Brands

Neurology Learning NetworkPediatrics Learning NetworkSurgery Learning Network

 

In the News

News
GLP-1 Receptor Agonists Linked to Reduced CRC Risk in Type 2 Diabetes Patients
05/06/2025
Riya Gandhi, MA
Patients on GLP-1RAs show lower colorectal cancer rates and higher colonoscopy use, pointing to a possible dual role in prevention and early detection.
Patients on GLP-1RAs show lower colorectal cancer rates and higher colonoscopy use, pointing to a possible dual role in prevention and early detection.
Patients on GLP-1RAs show lower...
05/06/2025
Gastroenterology
News
Use of Patient-Derived Organoids-Based Testing to Guide Neoadjuvant Treatment for Patients With Locally Advanced Thyroid Cancer
05/06/2025
Allison Casey
According to a single arm, phase 2 study, using patient-derived organoids-based testing has potential in guiding neoadjuvant therapy among patients with locally advanced thyroid cancer.
According to a single arm, phase 2 study, using patient-derived organoids-based testing has potential in guiding neoadjuvant therapy among patients with locally advanced thyroid cancer.
According to a single arm, phase...
05/06/2025
Oncology
News
Study Identifies Elevated Diabetes Risk in Veterans With Serious Mental Illness and Psychotropic Medication Use
04/22/2025
Hannah Musick
An expansive study of veterans found that serious mental illness and exposure to certain psychiatric medications significantly increase the risk of type 2 diabetes, with implications for tailored monitoring and treatment strategies.
An expansive study of veterans found that serious mental illness and exposure to certain psychiatric medications significantly increase the risk of type 2 diabetes, with implications for tailored monitoring and treatment strategies.
An expansive study of veterans...
04/22/2025
Veterans Health Today
News
First Allogeneic Pancreatic Islet Cellular Therapy Is Approved for Type 1 Diabetes
06/28/2023
Amanda Balbi
The FDA approved the new treatment based on positive results from 2 clinical trials that included 30 participants followed for more than 5 years.
The FDA approved the new treatment based on positive results from 2 clinical trials that included 30 participants followed for more than 5 years.
The FDA approved the new...
06/28/2023
Endocrinology & Diabetes
News
Class I Recall for Thyroid Medication
03/02/2023
Jolynn Tumolo
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to treat hypothyroidism is under a Class I recall because the medication may be subpotent.
A prescription drug used to...
03/02/2023
Pharmacy Learning Network
News
Assessing Bone Health in Long-term Care Residents With Diabetes
01/04/2023
Jolynn Tumolo
Providers should consider using measures such as trabecular bone score in addition to bone mineral density to understand the impact of diabetes on bone microarchitecture, researchers said.
Providers should consider using measures such as trabecular bone score in addition to bone mineral density to understand the impact of diabetes on bone microarchitecture, researchers said.
Providers should consider using...
01/04/2023
Annals of Long-Term Care
News
Complex Medication Regimens Associated With Poorer Type 2 Diabetes Outcomes
01/03/2023
Maria Asimopoulos
In addition to determining the link between regimen complexity and A1c, researchers recommended strategies for improving outcomes in underserved populations.
In addition to determining the link between regimen complexity and A1c, researchers recommended strategies for improving outcomes in underserved populations.
In addition to determining the...
01/03/2023
Pharmacy Learning Network
News
Does New-Onset Diabetes Predict Pancreatic Cancer?
01/02/2023
Priyam Vora
New studies identify individuals 50 years of age and older and with new-onset diabetes as a high-risk group for early pancreatic cancer and call for early screenings for timely detection.
New studies identify individuals 50 years of age and older and with new-onset diabetes as a high-risk group for early pancreatic cancer and call for early screenings for timely detection.
New studies identify individuals...
01/02/2023
Gastroenterology
News
Thyroid, Growth Hormones in Children Unaffected by 1 Year of Low-Dose ADHD Drugs
05/02/2022
Jolynn Tumolo
Low-dose medications to manage symptoms of attention-deficit/hyperactivity disorder (ADHD) do not appear to be associated with changes in thyroid and growth hormones over 1 year of treatment.
Low-dose medications to manage symptoms of attention-deficit/hyperactivity disorder (ADHD) do not appear to be associated with changes in thyroid and growth hormones over 1 year of treatment.
Low-dose medications to manage...
05/02/2022
Psych Congress Network
Diabetes Watch
Examining The Expanding Clinical Benefits Linked With Metformin Use
01/26/2022
Yvette C. Terrie, BS Pharm, RPh
In this column, the author outlines the latest evidence on the potential benefits of this medication, even outside the realm of type 2 diabetes.
In this column, the author outlines the latest evidence on the potential benefits of this medication, even outside the realm of type 2 diabetes.
In this column, the author...
01/26/2022
Podiatry Today

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use